- Home
- LAW vs VNDA Comparison
LAW vs VNDA Comparison
Compare LAW & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAW
- VNDA
- Stock Information
- Founded
- LAW 2013
- VNDA 2002
- Country
- LAW United States
- VNDA United States
- Employees
- LAW N/A
- VNDA N/A
- Industry
- LAW Computer Software: Prepackaged Software
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- LAW Technology
- VNDA Health Care
- Exchange
- LAW Nasdaq
- VNDA Nasdaq
- Market Cap
- LAW 308.5M
- VNDA 257.8M
- IPO Year
- LAW 2021
- VNDA 2006
- Fundamental
- Price
- LAW $5.26
- VNDA $4.43
- Analyst Decision
- LAW Hold
- VNDA Strong Buy
- Analyst Count
- LAW 5
- VNDA 2
- Target Price
- LAW $7.00
- VNDA $16.50
- AVG Volume (30 Days)
- LAW 124.7K
- VNDA 640.7K
- Earning Date
- LAW 02-20-2025
- VNDA 02-13-2025
- Dividend Yield
- LAW N/A
- VNDA N/A
- EPS Growth
- LAW N/A
- VNDA N/A
- EPS
- LAW N/A
- VNDA N/A
- Revenue
- LAW $144,841,000.00
- VNDA $198,772,000.00
- Revenue This Year
- LAW $5.24
- VNDA $16.07
- Revenue Next Year
- LAW $4.64
- VNDA $24.42
- P/E Ratio
- LAW N/A
- VNDA N/A
- Revenue Growth
- LAW 4.89
- VNDA 3.18
- 52 Week Low
- LAW $4.67
- VNDA $3.71
- 52 Week High
- LAW $8.57
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- LAW 52.13
- VNDA 44.53
- Support Level
- LAW $4.89
- VNDA $4.34
- Resistance Level
- LAW $5.58
- VNDA $4.65
- Average True Range (ATR)
- LAW 0.22
- VNDA 0.21
- MACD
- LAW 0.00
- VNDA -0.01
- Stochastic Oscillator
- LAW 58.31
- VNDA 36.51
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.